Skip to content

The effect of low dose Dexmedetomidine to prolong spinal anesthesia in elderly patients

The effect of low dose Dexmedetomidine to prolong spinal anesthesia in elderly patients

Status
Unknown
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240404001
Enrollment
38
Registered
2024-04-04
Start date
2022-12-27
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly (60-80 years old) undergoing Transurethral Resection of the Prostate under spinal anesthesia dexmedetomidine, elderly, Transurethral Resection of the Prostate, TURP, spinal anesthesia, prolong, intravenous

Interventions

intravenous Dexmedetomidine 0.4 mcg/kg total 10 ml,intravenous NSS 10 ml
Experimental Drug,Placebo Comparator No treatment
Dexmedetomidine group,NSS group

Sponsors

Faculty of Medicine Ramathibodi Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age 60-80 years 2.ASA physical status 1-3 3.undergoing Transurethral Resection of the Prostate under spinal anesthesia 4.inform consent before 5.pass cut-off point of MMSE-Thai 2002 for cognitive impairment

Exclusion criteria

Exclusion criteria: 1.patient refuse to participate 2.contraindication to spinal anesthesia 3.allergy to drug in trial 4.liver cirrhosis 5.end stage renal disease 6.Bradycardia ((heart rate <=50 bpm))

Design outcomes

Primary

MeasureTime frame
Two-dermatome regression until Two-dermatome regression Two-dermatome regression test every 10 min

Secondary

MeasureTime frame
Visual analog scale 0, 6, 12, 24 hours Visual analog scale

Countries

Thailand

Contacts

Public ContactChatchayapa Rathanasutthajohn

Faculty of medicine Ramathibodi Hospital, Mahidol University

chatchayapa.rat@gmail.com0880055358

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026